Charles River Laboratories International, Inc.CRLNYSE
Loading
A mid-sized company, operating profitably with revenues declining
Charles River Laboratories International, Inc. , a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing).
Comprehensive financial statement data for deep analysis
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Return on Equity | - | - | - | - | - |
| Return on Invested Capital | - | - | - | - | - |
| Gross Margin | 36.7% | 37.7%↑2.7% | 36.8%↓2.4% | 36.4%↓1.1% | 32.9%↓9.6% |
| Operating Margin | 14.8% | 16.7%↑12.6% | 16.4%↓1.7% | 14.9%↓8.7% | 5.6%↓62.4% |
| Net Margin | 12.5% | 11.0%↓11.4% | 12.2%↑10.7% | 11.5%↓6.0% | 0.3%↓97.8% |
| Earnings Yield | - | - | - | - | - |